Taro Kishi

8.3k total citations
233 papers, 5.5k citations indexed

About

Taro Kishi is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Taro Kishi has authored 233 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Psychiatry and Mental health, 42 papers in Pharmacology and 41 papers in Cellular and Molecular Neuroscience. Recurrent topics in Taro Kishi's work include Schizophrenia research and treatment (81 papers), Bipolar Disorder and Treatment (59 papers) and Treatment of Major Depression (37 papers). Taro Kishi is often cited by papers focused on Schizophrenia research and treatment (81 papers), Bipolar Disorder and Treatment (59 papers) and Treatment of Major Depression (37 papers). Taro Kishi collaborates with scholars based in Japan, United States and United Kingdom. Taro Kishi's co-authors include Nakao Iwata, Shinji Matsunaga, Yuki Matsuda, Toshikazu Ikuta, Kenji Sakuma, Tsuyoshi Kitajima, Reiji Yoshimura, Tomo Okochi, Norio Ozaki and Kazuto Oya and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Surgery.

In The Last Decade

Taro Kishi

226 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taro Kishi Japan	42	1.9k	1.1k	990	883	834	233	5.5k
Yiru Fang China	42	1.6k 0.8×	643 0.6×	965 1.0×	1.1k 1.2×	1.3k 1.6×	257	5.6k
Robert A. McCutcheon United Kingdom	31	2.7k 1.4×	1.5k 1.4×	715 0.7×	1.3k 1.4×	1.3k 1.6×	118	6.4k
Reiji Yoshimura Japan	36	1.4k 0.7×	1.2k 1.2×	823 0.8×	507 0.6×	1.2k 1.5×	276	4.8k
Diana De Ronchi Italy	33	1.1k 0.6×	848 0.8×	856 0.9×	692 0.8×	600 0.7×	157	3.9k
Gabriella Juhász Hungary	38	1.3k 0.7×	803 0.8×	672 0.7×	558 0.6×	569 0.7×	163	4.1k
Thomas C. Baghai Germany	45	1.3k 0.7×	1.7k 1.6×	1.2k 1.2×	1.3k 1.5×	1.5k 1.8×	170	6.7k
Hsien‐Yuan Lane Taiwan	38	1.6k 0.8×	1.4k 1.3×	542 0.5×	1.2k 1.4×	1.1k 1.3×	138	5.0k
Katherine J. Aitchison United Kingdom	44	1.9k 1.0×	746 0.7×	1.1k 1.1×	664 0.8×	1.7k 2.1×	159	6.0k
I. Nicol Ferrier United Kingdom	41	2.5k 1.3×	1.3k 1.2×	1.1k 1.1×	931 1.1×	811 1.0×	112	6.3k
Raffaella Zanardi Italy	38	1.7k 0.9×	1.3k 1.2×	1.5k 1.5×	847 1.0×	909 1.1×	134	4.3k

Countries citing papers authored by Taro Kishi

Since Specialization

Citations

This map shows the geographic impact of Taro Kishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Kishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Kishi more than expected).

Fields of papers citing papers by Taro Kishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Kishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Kishi. The network helps show where Taro Kishi may publish in the future.

Co-authorship network of co-authors of Taro Kishi

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Kishi. A scholar is included among the top collaborators of Taro Kishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Kishi. Taro Kishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kishi, Taro, Toshikazu Ikuta, Leslie Citrome, et al.. (2025). Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis. Translational Psychiatry. 15(1). 211–211. 2 indexed citations

Kishi, Taro, et al.. (2024). Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression. Pharmacopsychiatry. 57(5). 245–248.

Kishi, Taro, Kenji Sakuma, Masakazu Hatano, Makoto Okuya, & Nakao Iwata. (2023). Early relapse after antidepressant discontinuation may represent antidepressant discontinuation syndrome in major depressive disorder: A meta-analysis. Asian Journal of Psychiatry. 82. 103502–103502. 2 indexed citations

Kishi, Taro, et al.. (2023). Acceptability of antipsychotic transdermal patch for acute schizophrenia: a systematic review and meta‐analysis. Psychiatry and Clinical Neurosciences. 78(4). 260–262.

Kishi, Taro, Kenji Sakuma, Yuki Matsuda, Shinsuke Kito, & Nakao Iwata. (2023). Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder: A systematic review and meta-analysis. Psychiatry Research. 328. 115452–115452. 18 indexed citations

Kishi, Taro, Toshikazu Ikuta, Kenji Sakuma, et al.. (2022). Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Molecular Psychiatry. 28(1). 402–409. 71 indexed citations

Kakeda, Shingo, Asuka Katsuki, Koichiro Sugimoto, et al.. (2018). Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience. 269(7). 785–794. 12 indexed citations

Kishi, Taro, Toshikazu Ikuta, Shinji Matsunaga, et al.. (2017). Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Neuropsychiatric Disease and Treatment. Volume 13. 1281–1302. 17 indexed citations

Ueda, Issei, Shingo Kakeda, Keita Watanabe, et al.. (2016). Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study. PLoS ONE. 11(3). e0150712–e0150712. 16 indexed citations

10.

Kishi, Taro, Shinji Matsunaga, & Nakao Iwata. (2016). Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. European Archives of Psychiatry and Clinical Neuroscience. 267(2). 149–161. 11 indexed citations

11.

Kishi, Taro, Yuki Matsuda, Hiroshi Nakamura, & Nakao Iwata. (2012). Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials. Journal of Psychiatric Research. 47(2). 149–154. 56 indexed citations

12.

Matsuda, Akihisa, Taro Kishi, Asha Jacob, Monowar Aziz, & Ping Wang. (2012). Association between insertion/deletion polymorphism in angiotensin-converting enzyme gene and acute lung injury/acute respiratory distress syndrome: a meta-analysis. BMC Medical Genetics. 13(1). 76–76. 34 indexed citations

13.

Kishi, Taro, Tomo Okochi, Tsuyoshi Kitajima, et al.. (2011). Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(7). 1618–1622. 3 indexed citations

14.

Kishi, Taro, Yasuhisa Fukuo, Reiji Yoshimura, et al.. (2010). Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population. Human Psychopharmacology Clinical and Experimental. 25(6). 481–486. 12 indexed citations

15.

Kishi, Taro, Reiji Yoshimura, Tsuyoshi Kitajima, et al.. (2010). SIRT1 gene is associated with major depressive disorder in the Japanese population. Journal of Affective Disorders. 126(1-2). 167–173. 108 indexed citations

16.

Kishi, Taro, Reiji Yoshimura, Tomo Okochi, et al.. (2010). Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology. 58(7). 1168–1173. 33 indexed citations

17.

Kishi, Taro, Tomoko Tsunoka, Masashi Ikeda, et al.. (2009). Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. Journal of Human Genetics. 54(11). 629–633. 55 indexed citations

18.

Kishi, Taro, Reiji Yoshimura, Tsuyoshi Kitajima, et al.. (2009). HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort. NeuroMolecular Medicine. 12(3). 237–242. 43 indexed citations

19.

Kishi, Taro, Tomo Okochi, Masashi Ikeda, et al.. (2009). Translin-Associated Factor X Gene (TSNAX) may be Associated with Female major Depressive Disorder in the Japanese Population. NeuroMolecular Medicine. 12(1). 78–85. 12 indexed citations

20.

Kishi, Taro, Masashi Ikeda, Tsuyoshi Kitajima, et al.. (2007). No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a japanese population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(4). 531–534. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact